Stifel Trust’s AbbVie ABBV Stock Holding History

Stifel Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$326K	Hold	5,630	–	–	0.06%	158
2014 Q2	$318K	Buy	5,630 +200	+4%	+$10.5K	0.06%	158
2014 Q1	$280K	Sell	5,430 -175	-3%	-$8.84K	0.05%	157
2013 Q4	$297K	Sell	5,605 -100	-2%	-$4.92K	0.06%	160
2013 Q3	$256K	Sell	5,705 -300	-5%	-$13.3K	0.05%	165
2013 Q2	$249K	Buy	+6,005	New	+$263K	0.05%	165

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stifel Trust's ABBV Position: Q3 2014 in Review

Stifel Trust held its AbbVie (ABBV) position steady in Q3 2014 at 5,630 shares worth $326K. The position accounts for 0.06% of the portfolio, ranked #158.

Stifel Trust first reported a position in ABBV in Q2 2013 and has held it in 6 quarters since. 1,501 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

Stifel Trust held 5,630 shares of AbbVie worth $326K as of Q3 2014.
Stifel Trust left its AbbVie share count unchanged in Q3 2014.
AbbVie made up 0.06% of Stifel Trust's portfolio in Q3 2014, its #158 holding.
Stifel Trust first reported a position in AbbVie in Q2 2013 and has held it in 6 quarters since.
1,501 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.